Scientists have discovered a critical part of the body’s immune system with potentially major implications for the treatment of some of the most devastating diseases affecting humans.
Professor Graham Lord, from The University of Manchester, led the study, which could translate into treatments for autoimmune diseases including Cancer, Diabetes, Multiple Sclerosis and Crohn’s Disease within a few years.
It is published in The Journal of Clinical Investigation today.
The discovery of the molecular pathway regulated by a tiny molecule – known as microRNA-142 – is a major advance in our understanding of the immune system.
The 10-year-study found that microRNA-142 controls Regulatory T cells, which modulate the immune system and prevent autoimmune disease. It is, they found, the most highly expressed regulator in the immune system.
Autoimmune diseases often target people in the prime of their life creating a significant socio-economic burden on them. Sometimes, the effect can be devastating, causing terrible hardship and suffering. But these findings represent a significant step forward in the understanding of the immune system and we believe many people worldwide may benefit
Professor Graham Lord
And according to Professor Lord, the discovery could be translated into a viable drug treatment within a few years.
He said: “Autoimmune diseases often target people in the prime of their life creating a significant socio-economic burden on them. Sometimes, the effect can be devastating, causing terrible hardship and suffering.
“But these findings represent a significant step forward in the understanding of the immune system and we believe many people worldwide may benefit.”
If the activity of Regulatory T cells is too low, this can cause other immune cells to attack our own body tissues. If these Regulatory T cells are too active, this leads to suppression of immune responses and can allow cancers to evade the immune system.
So being able to control them is a major step forward in our ability to control- and harness – the therapeutic power of the immune system.
Professor Richard Jenner from UCL, who led the computational side of the project, said that: “We were able to trace the molecular fingerprints of this molecule across other genes to determine how it acted as such a critical regulator.”
Professor Lord, now Vice President and Dean of the Faculty of Biology, Medicine and Health at The University of Manchester, added: “Scientists over the past decade or so have developed therapies which are able to modulate different pathways of the immune system. We hope that this new discovery will lead to the development of new ways to treat autoimmunity, infectious diseases and cancer and we are incredibly excited about where this may lead.”
The Latest on: Autoimmune diseases
via Google News
The Latest on: Autoimmune diseases
- Rituximab Maintenance Therapy for Autoimmune Pancreatitis on April 17, 2019 at 11:26 am
The dramatic response to steroids makes autoimmune pancreatitis (AIP) unique among pancreatic disorders. However, some cases are steroid-resistant, and relapse is common after steroid withdrawal. Mayo ... […]
- Flying the Checkered Flag for Autoimmune Disease Awareness, Kyle Marcelli Races to Mid-Ohio after Back-to-Back Victories in 2018 on April 17, 2019 at 5:13 am
LEXINGTON, Ohio, April 17, 2019 /PRNewswire-PRWeb/ -- On May 3, Kyle Marcelli will return to Mid-Ohio SportsCar Course after last year's "Cinderella story," back-to-back IMSA victories. […]
- Fibromyalgia & Autoimmune Disease Treatment and Management on April 14, 2019 at 12:09 am
ALBURY, Australia - April 14, 2019 - PRLog -- Fibromyalgia, CFS and Autoimmune Disease. 'Fibromyalgia has been shown to affects roughly 10-15% of the population in given areas at any time, with ... […]
- Immunic Therapeutics and Vital Therapies Complete Transaction Creating Nasdaq-Listed Company Targeting Chronic Inflammatory and Autoimmune Diseases on April 13, 2019 at 10:06 am
- Lead Program, IMU-838, Already Advanced into Phase 2 Studies in Ulcerative Colitis and Relapsing-Remitting Multiple Sclerosis - - Proceeds of approximately USD 30 million from concurrent ... […]
- Environment May Play Role in Autoimmune Liver Disease on April 12, 2019 at 11:31 am
VIENNA -- Evidence of spatial clustering of autoimmune liver disease cases was observed in certain parts of England, suggesting environmental factors may be at play, a researcher here said. ... […]
- Understanding Your Autoimmune Disease on April 12, 2019 at 10:13 am
Soldiers are holding their positions, waiting for the signal to attack once the enemy is in sight. But hold on, what’s happening? Suddenly soldiers are firing on their own comrades. This isn’t ... […]
- Reducing your risk of autoimmune diseases on Coast Live on April 11, 2019 at 9:54 am
HAMPTON ROADS, Va. - As celebrities like Selena Gomez and Lady Gaga share their struggles with autoimmune disorders, more people are becoming aware of the long-lasting effects. Dr. Erica Steele ... […]
- Autoimmune diseases of the liver may be triggered by exposure to an environmental factor on April 11, 2019 at 12:28 am
Investigators from a large population-based study conducted in northern England have suggested that exposure to a persistent, low-level environmental trigger may have played a role in the ... […]
- Autoimmune Disease Diagnostics Market Opportunity, Major Driving Factors and Business Growth Strategies 2025 on April 10, 2019 at 7:46 am
Apr 10, 2019 (Heraldkeeper via COMTEX) -- Autoimmune Disease Diagnostics Market report provides major statistics on the state of the industry and is a valuable source of opportunities and developments ... […]
- Autoimmune Disease Market 2019 Global Industry Outlook By Size, Share, Trends, Growth, Key Players, Statistics, And Key Country Forecast To 2023 on April 10, 2019 at 7:37 am
Market Research Future (MRFR)’s latest assessment reveals that the global autoimmune disease treatment market is expected to thrive at 11.2% CAGR during the forecast period 2017 to 2023. The market ... […]
via Bing News